Receptor tyrosine kinases (RTK) constitute a large family of membrane receptors which, in response to their respective ligand, transmit information into cells. RTK regulate multiple biological responses, and their deregulation is often associated with tumourigenesis. The intracellular signalling pathways initiated by full-length membrane RTK are studied extensively, but many RTK fragments showing unexpected cellular localization have been observed. These fragments are generated by proteolytic cleavages, catalyzed notably by caspases, membrane metalloproteases or g-secretase. Interestingly, these cleavages, in addition to regulating membrane receptor levels, generate active fragments that can regulate biological processes, such as transcription or the survival/apoptosis balance. Thus, proteolytic cleavages release RTK from the membrane and extend their functions. Furthermore, the RTK proteolysis are involved in regulating cell transformation, which highlights their potential as attractive targets for therapeutic strategies. Keywords: receptor tyrosine kinase; cleavages; caspase; metalloprotease; g-secretase; signalling
In multicellular organisms, the dialogue between cells is crucial to harmonious development and, in adults, to tissue homeostasis. This dialogue operates notably through soluble cytokines and their cognate membrane receptors. Cytokines secreted by cells into the extracellular environment can bind with high affinity to the extracellular domains of their respective specific membrane receptors expressed on the surface of target cells. Ligand binding triggers activation of the receptor, which transmits the information from the extracellular to the intracellular compartment. Receptor tyrosine kinases (RTK) constitute a large family of information-transmitting membrane receptors. The variability of their extracellular regions results in a wide specificity range as regards cytokine ligands. Inversely, their intracellular regions possess a conserved tyrosine kinase domain, involved in message transmission (Hubbard and Till, 2000) . Ligand-activated RTK can initiate multiple biological responses, including proliferation, cell motility, survival and differentiation.
Receptor tyrosine kinases are activated through dimerization and trans-autophosphorylation of tyrosine residues. The intracellular region of an RTK then becomes a signalling platform that can recruit numerous cytoplasmic proteins through phosphorylated tyrosine residues. In turn, these signalling proteins activate signalling pathways commonly organized in a cascade, which will propagate the information inside the cell (Schlessinger, 2000) . The signalling cascades are often interconnected and are able to activate or downregulate each other (Amit et al., 2007) . Therefore, the entire intracellular signalling mechanism is viewed as a network rather than as a superposition of multiple linear pathways.
In keeping with the involvement of RTK in controlling a wide range of biological responses, their deregulation is associated with numerous types of cancer. Uncontrolled RTK activation involves several mechanisms, including tyrosine kinase activation by mutations, generation of constitutive fusion through chromosomal translocation, and in most cases, aberrant overexpression of the RTK and/or its ligand, leading to an autocrine or paracrine activation loop (Kolibaba and Druker, 1997) .
RTK are more than membrane receptors
The signalling pathways initiated by ligand-activated membrane-anchored RTK are studied extensively, the challenge being to unravel the relationship between activated signalling pathways and integrated biological responses. Yet RTK do not exist only at the cell surface; they have been observed in the extracellular environment, the cytoplasm and even in the nucleus. These unexpected locations are mostly the consequence of proteolytic cleavages. Recently, the molecular mechanisms underlying these RTK cleavages have been decrypted. In this review, we describe these recent findings, involving caspases, membrane metalloproteases and the g-secretase complex as proteases targeting RTK. Interestingly, in addition to inactivating RTK, the proteolytic cleavages generate active fragments acting in other cell compartments. Thus, in parallel with the classical signalling cascades initiated by full-length membrane RTK, novel signalling mechanisms have emerged, in which proteolytic fragments, like emissaries, transmit information directly.
RTK are reaped by caspases
Apoptotic cell death is triggered by a variety of physiological and pathological stimuli. Its characteristic morphological features include cell rounding, membrane blebbing, cytoplasmic condensation and DNA fragmentation. During apoptosis, caspases forming a family of cystein-dependent aspartate-directed proteases, can cleave a wide range of substrates contributing to the characteristic morphological modifications of apoptosis (Luthi and Martin, 2007) . Caspases can also contribute to promoting cell death by inactivating survival mechanisms. They can notably cleave several RTK, which are the major mediators of the survival response.
The Epidermal Growth Factor Receptor (EGFR), a member of the EGFR family, mediates critical survival signals, but in response to a variety of apoptotic stimuli, it is downregulated by activated caspases (Bae et al., 2001; He et al., 2003; Zhuang et al., 2003; He et al., 2006) that cleave the receptor within its C-terminal tail ( Figure 1a) . Interestingly, cells expressing uncleavable EGFR show slightly delayed cell death. This suggests that caspase cleavages suppress potential survival signalling through the downregulation of EGFR, identifying caspases as modulators of cell signalling (He et al., 2006) .
RTK are on the way to dependence
The caspase cleavages of EGFR proteins fail to generate detectable stable fragments. In contrast, caspase cleavages of the RTK RET, Met, TrkC, ALK, ErbB2 and EphA4 generate fragments acting directly on cell fate (Bordeaux et al., 2000; Tikhomirov et al., 2005; Benoit et al., 2004; Tulasne et al., 2004; Mourali et al., 2006; Foveau et al., 2007; Tauszig-Delamasure et al., 2007; Strohecker et al., 2008; Furne et al., 2009) . These fragments, generated by one or several cleavages, isolate the entire kinase domain of Met and RET, create a truncated kinase domain from TrkC, ALK and EphA4 or from the C-terminal truncation in ErbB2 (Figure 1a) . Thus, these cleavages dissociate the extracellular ligandbinding domain from the kinase domain or the C-terminal binding site for signalling proteins, thereby potentially abolishing the receptor function. Interestingly, the cytoplasmic fragments generated from RET, Met, TrkC and ErbB2, as well as from the remaining membrane-anchored fragment of ALK and EphA4 can all promote apoptosis. Therefore, in addition to inactivating these survival receptors, the caspase cleavages convert them to proapoptotic factors ( Figure 1a) . In contrast, except in the case of the orphan receptor, ErbB2, ligand stimulation inhibits the caspase cleavage of these receptors, probably through inhibition of caspase activity after induction of survival responses. Thus, the proteolytic RTK fragments generated by the caspase cleavage can promote apoptosis, a response opposite to the survival signalling induced by the ligandactivated full-length receptor (Figure 1b) . It is worth noting that although ErbB2 is an orphan receptor, it is able to contribute to cell survival through its association with other EGFRs or through its overexpression in tumour cells.
The proapoptotic function mediated by these RTK in the absence of their respective ligands, contrasting with their anti-apoptotic function upon ligand stimulation, is the hallmark of the emerging family of dependence receptors. Although a receptor is usually considered inactive until bound by its ligand, these receptors have been shown to induce cell death in the absence of the ligand. Thus, expression of these receptors leads to dependence on the ligand for cell survival (Bredesen et al., 2005) . Very little is known about the physiological involvement of the proapoptotic fragments released from RTK. However, it has been shown that ligand-activated TrkC induces neuron survival, whereas ligand withdrawal induces apoptosis. Interestingly, caspase-uncleavable TrkC impairs apoptosis induced by ligand withdrawal, showing that this neuronal cell death is not caused only by the loss of a survival response, but also to a proapoptotic activity induced by cleaved TrkC (Tauszig-Delamasure et al., 2007) . EphA4 is also involved in regulating the survival/ apoptosis balance in the nervous system. Indeed, EphA4-deficient mice show excessive numbers of neuroblasts in the sub-ventricular zone, whereas the absence of its ligand, the EphrinB3, results in increased cell death. Furthermore, treatment with soluble EphrinB3 into the lateral ventricle reduced cell death. Altogether, these observations support the involvement of EphA4 in neurogenesis through a dependence mechanism (Furne et al., 2009 ). In the case of RET, cleavage by caspases has been linked to Hirschsprung's disease (an intestinal malformation characterized by the absence of parasympathetic neurons in the hindgut), as Hirschsprung's-associated RET mutations impair the ligand downregulation of RET proapoptotic activity (Bordeaux et al., 2000) . Thus, caspase cleavages of these three RTK are associated with the regulation of the neuronal survival/apoptosis balance, a tightly regulated process. Met and ALK are also expressed in the developing nervous system, and ligand-activated Met induces neuron survival (Allouche, 2007; RunebergRoos and Saarma, 2007; Maina and Klein, 1999) . This raises the possibility that the proapoptotic properties showed by these receptors in the absence of the ligand might contribute to neuronal cell death during development. The future challenge will be to unravel the physiological relevance of caspase-dependent cleavage of RTK notably during development. With this aim, several laboratories are developing genetically modified mice expressing an uncleavable receptor mutated at the caspase site.
Both survival receptors and messengers of death
Although the survival signalling pathways activated upon RTK stimulation are well described, the down- (Hubbard and Till, 2000) and the identified caspase sites of receptor tyrosine kinase (RTK) are represented. On the left are represented the epidermal growth factor receptor (EGFR), inactivated by caspase cleavages, and the ErbB2 receptor, in which caspase cleavages generate apoptotic fragments. On the right are represented the RTK classified as dependence receptor, able to induce survival in response to their ligand and apoptosis through the generation of proapoptotic fragments. The identified addiction dependence domains (ADD) involved in the proapoptotic response are indicated. (b) Representation of the dependence mechanism induced by RTK. In the presence of ligand (on the left), activated RTK initiates survival signalling pathways, including activation of PI3-K-AKT signalling, which counteract apoptosis notably through the inhibition of caspase activity. In contrast, in the absence of ligand (on the right), some RTK are cleaved by caspases generating proapoptotic fragment able to regulate caspase activity and to amplify cell death. stream responses induced by RTK fragments remain poorly understood. The proapoptotic domain exposed upon caspase cleavage (named ADD for Addiction Dependence Domain in the dependence receptor family) differs among these RTK, extending through the entire kinase domain in RET and Met, being located in the N-terminal part of the kinase domain in TrkC, the Nterminal region of ErbB2 and within the juxtamembrane domain in ALK (Figure 1a ). These distinct locations suggest that these RTK might not share the same celldeath-promoting mechanism.
It has been shown in pituitary cells that the proapoptotic property of RET is associated with the formation of a complex between RET, caspase-3 and PKCd. This promotes RET cleavage, leading finally to p53 expression and apoptosis (Canibano et al., 2007) . In the case of ErbB2, it has been shown that the fragment generated through the caspase-dependent cleavage contains a BH3-like domain involved in its mitochondrial localization and its association with the anti-apoptotic protein, Bcl-x L . These properties are necessary for mitochondrial cytochrome c release and apoptosis induced by the ErbB2 fragment (Strohecker et al., 2008) . Thus, these receptors are able to promote cell death through the generation of fragments acting directly on the apoptotic machinery. In the light of these signalling mechanisms, we can propose that proapoptotic fragments of RTK act directly on the apoptotic process. This contrasts with the survival response, mediated by ligand-activated membrane receptors and based on the activation of signalling cascades (Figure 1b ).
Shedding releases RTK from the membrane
Cell-membrane-bound proteins can be cleaved proteolytically in the juxtamembrane region through a process called ectodomain shedding, releasing soluble extracellular domains. Ectodomain shedding is a widespread form of proteolytic processing affecting many proteins, including growth factors, cytokines, adhesion molecules, receptors and proteins of the immune system (Huovila et al., 2005) . Several extracellular RTK fragments have been observed in the extracellular medium. This unexpected localization is the consequence of ectodomain shedding, evidenced for at least 15 RTK (Table 1) .
The shedding activity is attributed to metalloproteases such as matrix metalloproteases (MMP) and A Disintegrins And Metalloproteases (ADAM) or to aspartic proteases (BACE). Among them, the ADAM proteins seem to be responsible for the majority of RTK shedding. Notable in this respect is ADAM17, initially identified as TNF-a-converting enzyme. It has been shown that ADAM17 cleaves CSFR, VEGFR2, ErbB4 and c-Kit, whereas EphB2 is processed by ADAM10 (Table 1 ). In addition, it has been shown that multiple sheddases can cleave the same substrate. Accordingly, we have shown that silencing of ADAM17 inhibits only partial shedding from Met, suggesting that other metalloproteases could process Met (Foveau et al., 2009) . Moreover, it has recently been shown in NIH3T3 cells that shedding from Met involves ADAM10 (Kopitz et al., 2007) . Thus, shedding from RTK could involve several metalloproteases, which could be engaged differently according to the cell type or the stimulus. However, for several RTK the proteases responsible for shedding are not yet known.
Shedding involving ADAM proteins can occur constitutively or in response to different stimuli, such as treatment with phorbol esters (PMA, phorbol myristate acetate), PKC activation, growth factor or cytokine stimulation and calcium influx (Blobel, 2005) (Table 1 ). In addition, shedding can be activated upon ligand stimulation, as evidenced for EGFR, CSFR, TrkA, and VEGFR (Table 1) . Different stimuli can activate shedding of the same RTK. For instance, Met shedding is reported to be induced by PMA (Crepaldi et al., 1994; Jeffers et al., 1997) , suramin (Galvani et al., 1995) , EGF and LPA (lysophosphatidic acid), HGF/SF (Wajih et al., 2002) , or by an antibody directed against the extracellular domain of Met (DN30) (Petrelli et al., 2006) . Although numerous stimuli are known to be involved in the modulation of shedding, the underlying mechanisms are poorly understood. However, it has been recently shown that mitogen-activated protein kinase (MAPK) pathways are involved in activating ADAM-mediated ectodomain shedding, as VEGF enhances ADAM17-mediated VEGFR2 shedding through the involvement of MAPK Erk and p38 and PKC, thereby also triggering shedding from other ADAM17 substrates (Swendeman et al., 2008) .
This proteolysis occurs within the extracellular juxtamembrane domain of the receptor, releasing the extracellular ligand-binding domain into the medium and generating cell-bound fragments. ADAM-mediated ectodomain shedding from cell adhesion molecules has been implicated in cell-cell interactions and in cell migration (Tousseyn et al., 2006) . For growth factors or cytokines, the main consequence of ectodomain shedding is to allow a membrane-anchored growth factor or cytokine (such as TNF-a or an EGFR ligand) to participate in paracrine signalling (Blobel, 2005) .
Although the biological involvement of RTK ectodomain shedding is less understood, this cleavage may play several roles in the regulation of RTK signalling. First, ectodomain shedding is involved in the downmodulation of RTK, as PMA-or ligand-stimulation-induced shedding from several RTK, such as CSF-1R (Downing et al., 1989) , c-Kit (Yee et al., 1994) and TrkA (DiazRodriguez et al., 1999) leads to their downregulation through a decrease in cell surface receptor. This downregulation might have functional consequences on RTK signalling, as PMA-induced shedding from TrkA prevents its ligand-induced autophosphorylation (Cabrera et al., 1996; Diaz-Rodriguez et al., 1999) .
In addition, the released extracellular domains might act as decoys associating with the ligand, which would then be unavailable for the full-length membrane-bound receptor (Figure 2 ). This potential decoy function is supported by the ability of some extracellular fragments to bind their ligand efficiently, as evidenced for the extracellular fragments of c-Kit and Met (Turner et al., 1995; Wajih et al., 2002) . Furthermore, conditioned medium containing shed Met fragments can inhibit intracellular signalling induced by ligand-activated fulllength receptor (Petrelli et al., 2006; Wajih et al., 2002) . Alternatively, ADAM-mediated shedding from RTK can initiate signalling pathways through generation of the membrane-bound fragment. The membrane-anchored fragments generated by shedding from TrkA and ErbB2 show increased autokinase activity (DiazRodriguez et al., 1999; Xia et al., 2004) . In addition, the membrane-bound fragment of TrkA can associate with signalling proteins, such as p85 PI3-K and PLCg, suggesting that the truncated fragment is signallingcompetent (Diaz-Rodriguez et al., 1999). In breast cancer cells, it has been shown that heregulin stimulates phosphorylation of the membrane-anchored fragment (p95 ErbB2 ) generated by the metalloprotease-dependent cleavage of ErbB2, when heterodimerized with ErbB3; this results in the activation of downstream signalling mediators, such as Akt (Xia et al., 2004) .
Downregulation of RTK by presenilin-dependent regulated intramembrane proteolysis
The role of shedding, notably in degradation, can be understood as part of a more complex process. Ectodomain shedding from several RTK by metalloprotease-dependent cleavage is also the checkpoint of another protease, the g-secretase complex (Table 1) . The g-secretase complex cannot efficiently cleave full-length type-1 proteins, such as RTK, and initial ectodomain removal is a prerequisite to intramembrane cleavage of the remaining stub (Brown et al., 2000) . Detailed genetic and biochemical studies have shown that this second cleavage involves the g-secretase complex, including APH-1, Nicastrin, Pen-2 and presenilin 1-2 as catalytic cores (De Strooper, 2003; Edbauer et al., 2003; Fraering et al., 2004; Parks and Curtis, 2007) . This proteolytic process in two sequential steps has been named Presenilin-dependent Regulated Intramembrane Proteolysis (PS-RIP). This mechanism plays a crucial role in Alzheimer's disease, as PS-RIP of amyloid precursor protein leads to the generation of the Ab fragments found in the brains of patients (Wilquet and De Strooper, 2004) . Three fragments are potentially generated by PS-RIP, namely an extracellular and soluble N-terminal fragment (NTF), an intermediate membrane-anchored C-terminal fragment (CTF) and an intracellular domain (ICD) generated by further cleavage by the g-secretase complex.
A common feature of the ICD generated from RTK is their high instability. As evidenced, for instance, for CSF-R, IGF-IR, Tie1, EphB2 and Met the ICD is rapidly degraded through a proteasome-dependent mechanism (Wilhelmsen and van der Geer, 2004; Litterst et al., 2007; Marron et al., 2007; McElroy et al., 2007; Foveau et al., 2009) (Figure 2) . Moreover, PS-RIP shares common features with the liganddependent degradation described for RTK, including endocytosis and ubiquitination. For instance, processing of the EphB2 receptor is greatly stimulated by the ephrinB ligand, which stimulates ubiquitination and rapid endosomal degradation of the intracellular fragment (Litterst et al., 2007) . Downregulation of RTK through PS-RIP also affects the associated signalling pathways. Indeed, as recently shown in the case of the RTK, Tie1, its proteolyses by PS-RIP leads to an amplified ligand activation of the associated receptor, Tie2 (Marron et al., 2007; McCarthy et al., 1999; Yabkowitz et al., 1999) . The authors propose that release of the extracellular domain of Tie1 permits ligand access to Tie2, presumably by preventing spatial hindrance.
On the whole, PS-RIP can be considered an efficient mechanism for clearing out the membrane-anchored domains of many type-1 proteins, a function that has earned this complex the name of proteasome of the membrane (Kopan and Ilagan, 2004) . Interestingly, the two steps of RTK PS-RIP, generating both a labile intracellular fragment and an extracellular soluble fragment, could participate together in downregulating receptor signalling, through both degradation of the intracellular tyrosine kinase domain and generation of an extracellular decoy inhibiting ligand activation of the remaining membrane-anchored receptor.
Both membrane receptors and transcriptional regulators
Although most PS-RIP-dependent fragments are extremely labile, some ICD are active fragments showing The CTF is cleaved in turn by the g-secretase complex, leading to the generation of a cytoplasmic fragment (or ICD for intracellular domain). The ICD fragments are extremely labile through their proteasomal degradation, which contributes to the downregulation of RTK. In addition, some ICD show nuclear localization and regulate gene transcription.
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physiological functions. For instance, the EGFR-family member, ErbB4, is cleaved sequentially by ADAM17 and g-secretase complex in response to neuregulin. Unexpectedly, this proteolysis generates an ICD fragment (ErbB4-ICD) showing nuclear localization (Cheng et al., 2003; Ni et al., 2001) . Furthermore, ErbB4-ICD is involved in regulating several biological responses triggered by ligand-activated ErbB4, according to the complex formed with different transcriptional regulators. In the lactating breast epithelium, ErbB4-ICD localizes to the nucleus with an intrinsic nuclear localization signal, promotes nuclear translocation of the transcription factor, STAT5A (signal transducer and activator of transcription 5A), and thereby activates the promoter of the b-casein-encoding gene (Williams et al., 2004; Vidal et al., 2005) . In contrast, ErbB4-ICD acts in astrocytes as a transcriptional repressor, through the formation of a complex with the adaptor, TAB2, and the co-repressor, N-CoR, which translocates into the nucleus to repress promoters of astrocytic genes (Sardi et al., 2006) . Importantly, the physiological involvement of this transcriptional repression has been evidenced during embryonic development; ErbB4 knockout mice show precocious astrogenesis, a phenotype rescued by the ectopic expression of PS-RIP-sensitive ErbB4 and ErbB4-ICD in electroporated embryos. PS-RIP of ErbB4 probably contributes to the regulation of additional physiological or pathological responses, as ErbB4-ICD interacts also with Mdm2, a regulator of p53, and ETO2, a transcriptional repressor (Arasada and Carpenter, 2005; . Nuclear signalling mediated by a membrane receptor fragment was initially evidenced for Notch. In response to the Notch ligand, Jagged, the generated ICD of Notch translocates into the nucleus, in which it binds transcription factors. This results in the displacement of negative co-repressors and in the transcription of Notchresponsive genes (Bray, 2006) . This mechanism is the canonical signalling pathway propagating Notch-dependent responses. In contrast, RTK were believed until recently to regulate transcription solely through the activation of protein kinase cascades that ultimately phosphorylate transcription factors, regulating their activity (Schlessinger, 2000) . Thus, PS-RIP might represent an alternative or parallel signalling pathway, in which generated proteolytic fragments themselves transmit information and act directly on the key regulators of transcription (Schlessinger and Lemmon, 2006) . Interestingly, the PS-RIP-dependent signalling could represent the major mechanism of signal transduction for a particular RTK. The Ryk RTK is a receptor of Wnt proteins required for the differentiation of neuronal progenitor cells during cortical development. However, unlike other RTK, Ryk lacks tyrosine kinase activity leaving unresolved its mechanism to transduce signal from the cell surface to the nucleus. It has been recently shown that Ryk is processed by the PS-RIP leading to the generation of a Ryk-ICD fragment that is able to translocate into the nucleus in response to the Wnt3 stimulation. The generation of Ryk-ICD is required for Wnt3-dependent differentiation of the primary culture of neuronal progenitor cells, showing that PS-RIP of Ryk represents an efficient mechanism of signalling required for neuronal determination (Lyu et al., 2008) . Other PS-RIP-dependent fragments of RTK have been observed in the nucleus, suggesting that the proteolytic cleavage could give these receptors the gift of ubiquity (Kasuga et al., 2007; Wilhelmsen and van der Geer, 2004) .
Proteolytic cleavages of RTK as gatekeepers of cell transformation
Deregulation of RTK signalling is one of the major molecular defects associated with tumourigenesis. In most cases, aberrant overexpression of an RTK and/or its ligand leads to an autocrine or paracrine activation loop. Although RTK overexpression has been attributed mainly to gene amplification or to increased transcriptional induction, aberrant RTK activation can also result from defective downregulation. For instance, deficient ligand-dependent downregulation of EGFR, Met, PDGFR, and CSFR (involving ubiquitination and lysosomal degradation) is associated with cell transformation (Bache et al., 2004) .
As both caspase cleavages and PS-RIP downregulate RTK expression and RTK-mediated biological responses, one might speculate that these processes could prevent tumourigenesis promoted by overexpressed RTK. In normal epithelial cells, accordingly, the PS-RIP-uncleavable Met receptor shows an extended half-life and membrane accumulation. Consequently, this receptor triggers ligand-independent biological responses, including cell migration (Foveau et al., 2009) .
Proteolytic cleavages can also prevent accumulation of deleterious fragments. Indeed, degradation of type I receptor by PS-RIP involves initial ectodomain shedding. However, for numerous RTK, truncation of the extracellular domain leads to the generation of active proteins often showing transforming properties. For IGFR, ErbB4 and Tie1, ectodomain shedding leads to the generation of constitutively phosphorylated membrane-tethered fragments, but their accumulation is prevented by g-secretase cleavage and subsequent degradation of the fragment Marron et al., 2007; McElroy et al., 2007) . Thus, g-secretase cleavage might be considered as a protective cleavage preventing the generation of transforming fragments.
In contrast, ectodomain shedding from ErbB2 is not followed by g-secretase cleavage. Consequently, in cancer cells overexpressing ErbB2, ectodomain shedding is associated with the accumulation of membraneanchored ErbB2-CTF fragment (or p95 ErbB2 ) (Christianson et al., 1998) . This fragment appears to be constitutively phosphorylated (Segatto et al., 1988; Molina et al., 2001) and is associated with worse outcome among patients overexpressing ErbB2 (Saez et al., 2006) . This suggests that ErbB2-CTF is a deleterious fragment. Furthermore, expression of the ErbB2-CTF fragment is associated with resistance to Herceptin treatment, Herceptin being a humanized antagonist antibody directed against ErbB2 and used to treat ErbB2-overexpressing metastatic breast cancers. ErbB2-CTF is indeed potentially insensitive to this antibody targeting the extracellular region of the receptor (Scaltriti et al., 2007) . In consequence, ADAM inhibition is envisaged as a novel therapeutic approach to optimize the activity of other treatments, such as Herceptin or tyrosine kinase inhibitor in overexpressed ErbB2 cancers (Liu et al., 2006; Witters et al., 2008) .
In addition to degrading RTK, proteolytic cleavages generate active fragments that might play a role in tumourigenesis. For instance, a g-secretase fragment of ErbB4 (ErbB4-ICD), which can translocate to the nucleus to regulate gene expression, can also promote apoptosis. This conclusion rests on the observation that ErbB4-ICD appears in the cytoplasm, in which it colocalizes with mitochondria. ErbB4-ICD can interact with Bcl-2 to promote Bak-dependent permeabilization of the mitochondria and apoptosis. Interestingly, ErbB4-ICD induces efficient apoptosis in various transformed cell lines, and in human breast tumours, an association between tumour cell apoptosis and cytoplasmic localization of ErbB4-ICD has been observed (Naresh et al., 2006; Vidal et al., 2007) . These observations suggest that PS-RIP of ErbB4 could counteract cell transformation through the generation of a proapoptotic fragment.
Deregulation of the survival/apoptosis balance in favour of survival is often associated with cell transformation. The deregulated activity of RET, TrkC, Met and ALK, four RTK classified as dependence receptors, is associated with various tumours sharing a common feature, namely constitutive tyrosine kinase activation induced by aberrant ligand expression, receptor overexpression or fusion of the kinase domain to dimerization domains (Runeberg-Roos and Saarma, 2007; Chiarle et al., 2008; Migliore and Giordano, 2008) . It has been established that the constitutive activation of these RTK contributes to cell transformation through the activation of signalling pathways that positively regulate survival, growth or motility. Yet one might speculate that ligand stimulation, which impairs the caspase-dependent cleavage of these receptors and thus, reduces their proapoptotic properties, might also contribute to cell transformation. According to this model, cell transformation favoured by cell survival would result from both activation of RTK-triggered positive signalling and inhibition of RTK proapoptotic properties.
From proteolysis to therapy
Receptor tyrosine kinases and their downstream signalling pathways are frequent targets of efforts to develop anti-cancer strategies (Gschwind et al., 2004 ). An example is the development of many antagonist antibodies, like Herceptin, directed against the RTK extracellular domain. Another attractive strategy might be to reinforce RTK proteolysis, for instance, so as to induce the degradation of an overexpressed receptor in transformed cells. In this line, an anti-Met antibody directed against the extracellular domain has been shown to downregulate expression of the receptor in Met-overexpressing cells and to hamper Met biological activity, including tumour growth in mice (Petrelli et al., 2006) . Interestingly, we have recently shown that this antibody reinforces Met PS-RIP, leading to Met downregulation (Foveau et al., 2009 ). Thus, a forced induction of PS-RIP of the RTK receptor by antagonist antibodies could be an attractive therapeutic strategy for preventing its uncontrolled activation.
Shedding from RTK generates extracellular fragments acting as decoy receptors owing to their efficient binding to the ligand (Turner et al., 1995; Wajih et al., 2002) . Although the physiological relevance of the RTK decoy function is largely unknown, decoy approaches have been developed as therapeutic strategies. An artificial soluble extracellular domain of Met or c-Kit can efficiently inhibit relevant ligand-induced cell responses (Dahlen et al., 2001; Kong-Beltran et al., 2004) , and a decoy Met receptor has been shown to prevent tumour growth in a mouse model (Michieli et al., 2004) .
The number of RTK known to be cleaved by caspases or PS-RIP has recently increased, suggesting that this type of regulation could be widespread within the family. Future challenges will be to understand relationships between canonical signalling cascades and these alternative signalling mechanisms, and to unravel the physiological relevance of fragments or truncated receptors in the multiple biological responses induced by RTK.
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